Depression and BMI influences the serum vascular endothelial growth factor level. (September 2014)
- Record Type:
- Journal Article
- Title:
- Depression and BMI influences the serum vascular endothelial growth factor level. (September 2014)
- Main Title:
- Depression and BMI influences the serum vascular endothelial growth factor level
- Authors:
- Elfving, Betina
Buttenschøn, Henriette N.
Foldager, Leslie
Poulsen, Pia H. P.
Grynderup, Matias B.
Hansen, Åse M.
Kolstad, Henrik A.
Kaerlev, Linda
Mikkelsen, Sigurd
Børglum, Anders D.
Wegener, Gregers
Mors, Ole - Abstract:
- <abstract abstract-type="normal"> <title>Abstract</title> <p>Recent studies suggest that the angiogenic cytokine vascular endothelial growth factor (VEGF) is involved in the pathogenesis of depression. However, only a few studies have investigated serum VEGF levels in individuals with depression, or the possible association between genetic variants within the <italic>VEGF</italic> gene and depression. The purpose of the present study was to investigate differences between serum VEGF levels in individuals with depression <italic>vs.</italic> control individuals, and associations between genetic markers located within <italic>VEGF</italic> and depression. In addition, determinants of the serum VEGF levels were identified. One-hundred and fifty-five depressed subjects and 280 controls were included in the study. All individuals returned a questionnaire and participated in a semi-structured diagnostic interview. Eleven single nucleotide polymorphisms were successfully analysed. VEGF levels were measured in serum by immunoassay and independent determinants of the serum VEGF level were assessed by generalized linear models.The main findings were that depression, severity of depression, previous depressive episodes, age and body mass index (BMI) were associated with higher serum VEGF levels. The genetic marker rs10434 was significantly associated with depression after correction for multiple testing, but not with the serum VEGF level. Our final model included depression and BMI as<abstract abstract-type="normal"> <title>Abstract</title> <p>Recent studies suggest that the angiogenic cytokine vascular endothelial growth factor (VEGF) is involved in the pathogenesis of depression. However, only a few studies have investigated serum VEGF levels in individuals with depression, or the possible association between genetic variants within the <italic>VEGF</italic> gene and depression. The purpose of the present study was to investigate differences between serum VEGF levels in individuals with depression <italic>vs.</italic> control individuals, and associations between genetic markers located within <italic>VEGF</italic> and depression. In addition, determinants of the serum VEGF levels were identified. One-hundred and fifty-five depressed subjects and 280 controls were included in the study. All individuals returned a questionnaire and participated in a semi-structured diagnostic interview. Eleven single nucleotide polymorphisms were successfully analysed. VEGF levels were measured in serum by immunoassay and independent determinants of the serum VEGF level were assessed by generalized linear models.The main findings were that depression, severity of depression, previous depressive episodes, age and body mass index (BMI) were associated with higher serum VEGF levels. The genetic marker rs10434 was significantly associated with depression after correction for multiple testing, but not with the serum VEGF level. Our final model included depression and BMI as predictors of serum VEGF levels. Our study suggests a role for circulating serum VEGF in depression. Furthermore, our data also demonstrate that other factors than a diagnosis of depression influence the serum VEGF level. The importance of these factors should be emphasized when studies are compared.</p> </abstract> … (more)
- Is Part Of:
- International journal of neuropsychopharmacology. Volume 17:Number 9(2014)
- Journal:
- International journal of neuropsychopharmacology
- Issue:
- Volume 17:Number 9(2014)
- Issue Display:
- Volume 17, Issue 9 (2014)
- Year:
- 2014
- Volume:
- 17
- Issue:
- 9
- Issue Sort Value:
- 2014-0017-0009-0000
- Page Start:
- 1409
- Page End:
- 1417
- Publication Date:
- 2014-09
- Subjects:
- Neuropsychopharmacology -- Periodicals
Neuropharmacology -- Periodicals
Psychopharmacology -- Periodicals
615.78 - Journal URLs:
- http://www.cambridge.org/ ↗
http://firstsearch.oclc.org ↗
http://journals.cambridge.org/action/displayJournal?jid=PNP ↗ - DOI:
- 10.1017/S1461145714000273 ↗
- Languages:
- English
- ISSNs:
- 1461-1457
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4084.xml